Chronic Hepatitis B Virus
Reports from I.H. Kim and co-researchers add new data to research in chronic hepatitis B virus
Published in Hepatitis Weekly, June 14th, 2010
"The authors assessed the efficacy and antiviral resistance of 48-week clevudine therapy versus lamivudine in treatment of naive patients with HBeAg positive chronic hepatitis B. In this retrospective study, a total of 116 HBeAg positive patients, who received 30 mg of clevudine once daily (n=53) or 100 mg of lamivudine once daily (n=63) for 48 weeks, were included. At week 48, clevudine therapy produced a significantly greater mean reductions in serum HBV DNA levels from baseline than lamivudine therapy (-5.2 vs. -4.2 log(10)IU/mL; P=0.005)," scientists writing in the Journal of Korean Medical Science report.
"Furthermore, a significantly higher proportion of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2010-06-14)
More Articles from Hepatitis Weekly
- Non-Alcoholic Steatohepatitis
Study data from Kochi Medical School, Department of Pharmacy update understanding of non-alcoholic steatohepatitis - Chronic Hepatitis
Findings from S.R. Shin et al in chronic hepatitis reported - Toll-Like Receptors
Mayo Clinic reports research in toll-like receptors - Antiretrovirals
New antiretrovirals research has been reported by F. Suzuki et al - Biomedical Engineering
New biomedical engineering research from Chang Gung Memorial Hospital outlined - Clinical Trial Research
New clinical trial research data have been reported by scientists at University of Washington - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
